Chetan Dev, et al. “LONG-TERM CARDIOVASCULAR OUTCOMES AND SAFETY PROFILE OF PCSK9 INHIBITORS IN HIGH-RISK POPULATIONS FOR SECONDARY PREVENTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: A COMPREHENSIVE META-ANALYSIS OF MORTALITY, MAJOR ADVERSE CARDIAC EVENTS, AND METABOLIC IMPACT”. Insights – Journal of Health and Rehabilitation, vol. 2, no. 2 (Health & Allied), Nov. 2024, pp. 381-8, https://doi.org/10.71000/ijhr199.